AAP recommendations expand second-season RSV protection criteria for children ages 8 to 19 months, plus infant COVID-19 ...
Targeting key cellular proteins may provide new opportunities to diagnose, prevent, and treat pulmonary arterial hypertension ...
IDSA recommendations emphasize the safety and importance of COVID-19, influenza, and RSV vaccines immunocompromised patients.
GE HealthCare issued updated use instructions for certain patient monitoring devices, according to an FDA alert.